Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Substance P ELISA Kit (AC3222)
Cat.#: ASET-1811
Specifications
Description Human Substance P ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Substance P concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.47 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2530 Rat Antidiuretic Hormone ELISA Kit (AC3941) Quantitative inquiry ASET-1866 Human Arc ELISA Kit (AC3277) Quantitative inquiry ASET-2413 Mouse Has3 ELISA Kit (AC3824) Quantitative inquiry ASET-1241 Rat Wnt5a ELISA Kit (AC2652) Quantitative inquiry ASET-1048 Human Profilin 1 ELISA Kit (AC2459) Quantitative inquiry ASET-1191 Mouse NMDAR2B ELISA Kit (AC2602) Quantitative inquiry ASET-1700 Mouse NG2 ELISA Kit (AC3111) Quantitative inquiry ASET-1900 Human Drebrin ELISA Kit (AC3311) Quantitative inquiry ASET-1819 Human mu Crystallin ELISA Kit (AC3230) Quantitative inquiry ASET-1978 Bovine TIMP1 ELISA Kit (AC3389) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket